Skip to main content
. Author manuscript; available in PMC: 2017 Jun 15.
Published in final edited form as: Eur J Pharmacol. 2016 Apr 1;781:53–59. doi: 10.1016/j.ejphar.2016.03.061

Figure 2. Dose-effect curves of ADL5859 (left) and LY2444296 (right) in the FST where the effect is the magnitude (%) of the decrease in immobility time.

Figure 2

The data in Fig. 1 were transformed into % reduction in immobility and were fitted to the dose-effect curves by nonlinear regression.